Bio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Misses Estimates By $0.54 EPS
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) posted its quarterly earnings results on Thursday. The medical research company reported $2.33 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.87 by ($0.54), Briefing.com reports. Bio-Rad Laboratories had a positive return on equity of 3.82% and a negative net margin of 5.86%. The […]
More Stories
Ryanair (NASDAQ:RYAAY) Upgraded at Wall Street Zen
Ryanair (NASDAQ:RYAAY – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating...
NLS Pharmaceutics (NASDAQ:NLSP) Upgraded at Wall Street Zen
NLS Pharmaceutics (NASDAQ:NLSP – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “sell”...
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Rating Upgraded by Wall Street Zen
NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating...
Powell Max (NASDAQ:PMAX) Cut to Strong Sell at Wall Street Zen
Powell Max (NASDAQ:PMAX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen to a “strong...
Regency Centers (NASDAQ:REG) Rating Lowered to Sell at Wall Street Zen
Regency Centers (NASDAQ:REG – Get Free Report) was downgraded by analysts at Wall Street Zen from a “hold” rating to...
Roku (NASDAQ:ROKU) Trading 2% Higher After Analyst Upgrade
Roku, Inc. (NASDAQ:ROKU – Get Free Report)’s share price rose 2% during mid-day trading on Friday after Bank of America...